Avanir Pharma (NASDAQ: AVNR) announced that data on the prevalence of symptoms for pseudobulbar affect (PBA), a distressing condition characterized ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE